Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Angela Coulter a King's Fund, London W1M 0AN, b Health Services Research Unit,
University of Aberdeen, Aberdeen AB25 2ZD
Correspondence to:
Dr Coulter acoulter{at}kehf.org.uk
Shared decision making, in which patients and health
professionals join in both the process of decision making and ownership of the decision made, is attracting considerable interest as a means by
which patients' preferences can be incorporated into clinical
decisions.1 When there are several treatment options which
may have different effects on the patient's quality of life, there is
a strong case for offering patients choice. Their active involvement in
decision making may increase the effectiveness of the treatment.
Trials are currently under way to test this hypothesis formally,
but there are good grounds for optimism. Patients with hypertension benefit if they are allowed to adopt an active rather than a passive role in treatment,
2 3
patients with breast cancer suffer less depression and anxiety if they are treated by doctors who adopt a
participative consultation style,4 and patients who are
more actively involved in discussions about the management of their
diabetes achieve better blood sugar control.5 Patients whose doctors are ignorant of their values and preferences may receive
treatment that is inappropriate to their needs.6-8
Patients cannot express informed preferences unless they are given
sufficient and appropriate information, including detailed explanations
about their condition and the likely outcomes with and without
treatment. Yet many report considerable difficulties in obtaining
relevant information.9 There are various reasons for this.
Health professionals frequently underestimate patients' desire for and
ability to cope with information. Consultation times are limited
If information materials are to be used to support treatment
decisions, they must contain scientifically reliable information and be
presented in a form that is acceptable and useful to patients. We have
recently completed a study evaluating patient information for 10 common
conditions or treatments. The methods have been described
elsewhere.10 All 10 topics (back pain, cataract,
depression, glue ear, high cholesterol, hip replacement, infertility,
menorrhagia, prostate enlargement, stroke rehabilitation) had been the
subject of systematic reviews providing a yardstick against which to
judge the clinical content of the material available.
Identification of materials
Review
General views
The patients identified a wide range of information needs and had
some clear ideas about the kinds of information that were needed at
particular times during the course of illness and treatment (box). Very
few of the materials reviewed met all these needs adequately. For
example, while many materials contained reasonably clear descriptions
of the disease and common symptoms, the causes and consequences of
conditions were much less well covered and information about prevalence
was often missing. These were serious omissions because focus group
participants were clear that they needed to understand the natural
history of the condition from which they were suffering in order to
help them cope with it. Many of these important omissions could have
been avoided if patients had been consulted about their information
needs before the materials were developed. All but four of the
publishers who returned our questionnaire claimed to have involved
patients or potential users in the development of the materials, but
for the most part this was restricted to asking individual lay readers
or consumer group representatives to comment on the design and content
of an existing draft. Very few had researched patients' information
needs before they started, and few had evaluated materials formally
before making them publicly available.
The specialists identified many inaccuracies and misleading
statements in the materials reviewed which could give a false impression of the likely effectiveness of treatments. The most common
fault was to give an overoptimistic view, emphasising benefits and
glossing over risks and side effects. Quantitative information about
recovery time and outcome probabilities was absent from most materials.
The assumption on the part of many information producers that patients
do not want to know about side effects was not borne out by the views
expressed in the focus groups. Most participants were adamant that they
did want to know the full picture, as long as it was presented in a
non-alarmist fashion. They indicated a preference for information that
is balanced and includes a careful and honest assessment of the pros
and cons of treatment. If outcome probabilities are unknown because
relevant research has not been carried out, it is best to be frank
about this rather than provide reassurance that may turn out to be false.
There is a fine balance between providing too little information
in a leaflet and too much. Focus group participants considered many
materials too introductory and basic to be helpful, but one or two
contained a great deal of technical detail that reviewers considered
unnecessary. The patients were clear that they wanted information about
the full range of treatment possibilities, including complementary
therapies or counselling. Some otherwise good quality materials failed
to provide information about certain treatments or management
strategies, presumably because they were not supported by evidence of
efficacy. Patients who had heard about these treatments found the
omissions frustrating and were keen to learn more. They would prefer
that the information was included together with an honest assessment of
whether or not the treatments are known to be effective. The patients
wanted to be told about things they could do themselves to manage the
problem or to avoid risks, but self care and prevention were not always
well covered in the materials we reviewed.
Many materials included prescriptive statements and lists of
"do's" and "don'ts" that were not supported by evidence. It
was very uncommon for materials to admit to scientific uncertainty or
variations in clinical opinion. Very few contained any information about the primary sources on which they were based, and it was rare to
find a discussion of the strength of research evidence for the claims
made. The survey of publishers showed an alarming vagueness about the
sources of evidence from which the information was drawn. Only two of
the materials we reviewed were explicitly based on systematic reviews
of research into treatment efficacy. It is very important that patient
information is based on the best and most up to date information
available. Reliance on the knowledge of individual doctors is not
sufficient as a guarantee of reliability. The best way to ensure that
information on treatment efficacy is scientifically based and accurate
is to conduct a systematic review of published reports or to base it on
a review contained in a quality assured database such as the
Cochrane Library.
Nearly a third of the materials we reviewed did not include
a publication date, so it was not possible for readers to judge whether
they were likely to contain out of date information. Some had been in
circulation for many years, and specialist reviewers pointed out that
many were indeed out of date and failed to include information about
new treatments or recent research evidence. The development of patient
information materials should not be seen as a one off exercise. It
requires a long term commitment to produce regular updates and to
withdraw out of date materials from circulation. It is helpful if
materials indicate a "shelf life," beyond which date readers should
be warned to seek alternative sources of information.
Several materials were criticised for being patronising, victim
blaming, dismissive, or promoting an attitude of "doctor knows best." Focus group participants indicated a preference for
information that was facilitative rather than prescriptive, honestly
optimistic rather than frightening or gloomy, and which related to them
personally. The use of pictures and diagrams was appreciated, but the
patients did not like "gory" or "scary" pictures. They
preferred materials that were structured and concise, with clear
headings, important sections highlighted, short blocks of text and a
good index. No clear preferences were identified for video, audio,
computer based, or printed materials. Focus group participants were
more concerned with the information content than with media, and
all types were appreciated if they contained useful
information.
The process: (1) Involve patients throughout the process The content: (1) Use patients' questions as the starting point While few of the materials included explicit statements of their
aims and who they were designed for, responses to the publishers' questionnaire showed that most were intended to educate patients or to
prepare them for specific treatments or surgical procedures. Only two
of the materials reviewed were explicitly designed to support informed
treatment choice. The didactic style of many of the materials was not
popular with the focus group participants. They were more enthusiastic
about materials which gave them a sense of empowerment. These included
materials which reassured them that they were not alone in experiencing
the symptoms, gave them ideas for self help, and suggested questions
they could ask the doctor. Participants appreciated features that
actively engaged them and helped them to record relevant information
for discussion in a clinical consultation, such as symptom diaries or
space to write down questions or points to remember.
These findings show that there is a great deal more to the
production of good quality patient information than is commonly assumed. Patients should be involved throughout the process, reliable sources of evidence must be used, and careful thought must be given to
the purpose of the information and the needs of the target audience.12 The box gives a checklist of points for
consideration by developers of patient information materials.
Our survey showed that there was a dearth of information designed
specifically to support patient involvement in treatment decisions,
despite the fact that many patients want to play a more active role and
patient involvement has been on the policy agenda for some years now.
The box outlines a series of questions that patients may want answers
to if they are to express informed preferences. It should be possible
to design information packages which address these questions honestly,
accurately, and in a form that is acceptable to
patients.
What is causing the problem? Am I alone? How does my experience compare with that of other
patients? Is there anything I can do myself to ameliorate the problem? What is the purpose of the tests and investigations? What are the different treatment options? What are the benefits of the treatment(s)? What are the risks of the treatment(s)? Is it essential to have treatment for this problem? Will the treatment(s) relieve the symptoms? How long will it take to recover? What are the possible side effects? What effect will the treatment(s) have on my feelings and
emotions? What effect will the treatment(s) have on my sex life? How will it affect my risk of disease in the future? How can I prepare myself for the treatment? What procedures will be followed if I go to hospital? When can I go home? What do my carers need to know? What can I do to speed recovery? What are the options for rehabilitation? How can I prevent recurrence or future illness? Where can I get more information about the problem or
treatments? The goals of the government's patient partnership strategy, which
aims to promote shared decision making,13 will not be met
unless patients are provided with good quality information about
diseases and treatments. We call on the NHS Executive to:
there
is often insufficient time to explain fully the condition and the
treatment choices. Health professionals may themselves lack knowledge
of treatment options and their effects. A solution to this problem is
to ensure that patients have access to written or audiovisual material,
to inform themselves and to use in discussion with health
professionals.
Summary points
If information materials are to be used to support patients'
involvement in treatment decisions, they must contain relevant,
research based data in a form that is acceptable and useful to patients
Current information materials for patients omit relevant data, fail to
give a balanced view of the effectiveness of different treatments, and
ignore uncertainties
Many information materials adopt a patronising tone
few actively
promote a participative approach to decision making
Groups producing information materials must start with needs defined by
patients, give treatment information based on rigorous systematic
reviews, and involve multidisciplinary teams (including patients) in
developing and testing the materials
![]()
Evaluating information materials
We surveyed self help groups, consumer and voluntary
organisations, professional bodies, health authorities and NHS trusts,
drug companies, private health insurers, and other commercial
organisations to identify relevant materials. The survey elicited
positive responses from 78 organisations, which, between them, provided
copies of 128 printed materials, eight audiotapes or prerecorded
telephone helplines, and four videos (see Appendix ). Materials were
selected for review if they referred to more than one treatment option
and included some reference to treatment outcomes.
We organised reviews of 54 materials (42% of those received) by
62 patients with personal experience of the specific health problems
and by 28 clinical or academic specialists who were familiar with the
available research evidence. The patients were recruited via newspaper
advertisements and self help groups. All had recent experience of one
of the health problems chosen for study. They participated in 10 focus groups (one for each health problem), in which they discussed
their information needs and their opinions about the specific
materials. The focus group discussions were audiotaped, transcribed,
and analysed using the framework method.11 Themes were
identified and charted independently by two of us (VE and DG). The
clinical specialists reviewed the materials independently using a
structured checklist. A questionnaire which was sent to the developers
of the materials elicited responses from publishers of 26 of the
materials reviewed (48%).
Patient focus groups reported considerable dissatisfaction with
their experiences of communication with health professionals. Most had
wanted much more information about their condition and treatment than
they had been given. Many did not feel they had been offered any
choices about their treatment, and some had not realised that there
were other options until they received the information materials we
sent them for review. Initial reactions to these materials were
enthusiastic
any information was better than nothing
but on closer
examination the patients became more critical. The specialists tended
to be more critical of the materials than the patients. The study
revealed many deficiencies in the information available; it also
provided suggestions on how patient information might be improved. We
highlight selected themes here.
![]()
Topics of relevance to patients
Patients need information to:
![]()
Information about effectiveness
![]()
Treatment options and self care
![]()
Dealing with uncertainty
![]()
Currency
![]()
Language, tone, and presentation
Checklist for patient information materials
(2) Involve a
wide range of clinical experts
(3) Be specific about the purpose of
the information and the target audience
(4) Consider the
information needs of minority groups
(5) Review the clinical
research evidence and use systematic reviews wherever possible
(6)
Plan how the materials can be used within a wider programme promoting
shared decision making
(7) Consider cost and feasibility of
distribution and updating when choosing media
(8) Develop a
strategy for distribution
(9) Evaluate the materials and their
use
(10) Make arrangements for periodic review and updating
(11) Publicise the availability of the information materials
(2)
Ensure that common concerns and misconceptions are addressed
(3)
Refer to all relevant treatment or management options
(4) Include
honest information about benefits and risks
(5) Include
quantitative information where possible
(6) Include checklists and
questions to ask the doctor
(7) Include sources of further
information
(8) Use non-alarmist, non-patronising language in
active rather than passive voice
(9) Design should be structured
and concise with good illustrations
(10) Be explicit about
authorship and sponsorship
(11) Include reference to sources and
strength of evidence
(12) Include the publication date
![]()
Participation in decision making
![]()
Improving quality
Questions commonly asked by patients
![]()
Task for the NHS Executive
| |
Acknowledgments |
|---|
Informing Patients, the full report of the study, which includes detailed reviews of the information materials, is available from the King's Fund bookshop, price £16.95.
Funding: NHS Research and Development programme on evaluating methods to promote the implementation of research findings.
Competing interests: None declared.
| |
References |
|---|
| |
Appendix: Information materials obtained for the study |
|---|
Asterisks indicate materials reviewed.
Commercial publishers/private health care:
Butterworth-Heinemann (back pain)
Consumer groups/voluntary organisations:
Arthritis Care (hip replacement)
Drug and equipment manufacturers:
Bencard (prostate enlargement)
NHS organisations:
Bedfordshire Health Authority (glue ear*)
Professional/academic bodies:
Action Research (back pain)